Novocure
NVCR
#5447
Rank
₹110.74 B
Marketcap
Country
₹990.54
Share price
-2.28%
Change (1 day)
-43.13%
Change (1 year)
Categories
Earnings for Novocure (NVCR)
Earnings in 2025 (TTM): -₹9.9 Billion
According to Novocure 's latest financial reports the company's current earnings are ₹0.62 Billion. In 2024 the company made an earning of -₹10.53 Billion, an increase over its 2023 earnings that were of -₹16.41 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Novocure from 2015 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -₹9.9 Billion | -5.95% |
| 2024 | -₹10.53 Billion | -35.88% |
| 2023 | -₹16.41 Billion | 139.99% |
| 2022 | -₹6.84 Billion | 61.43% |
| 2021 | -₹4.24 Billion | -235.99% |
| 2020 | ₹3.11 B | 630.75% |
| 2019 | ₹0.42 B | -115.08% |
| 2018 | -₹2.83 Billion | -15.13% |
| 2017 | -₹3.33 Billion | -66.9% |
| 2016 | -₹10.07 Billion | 10.26% |
| 2015 | -₹9.13 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | -₹10.21 Billion | 0.00% | Jersey |
 Novavax NVAX | ₹44.42 B | -535.46% | 🇺🇸 USA |
 Organovo ONVO | -₹0.22 Billion | -97.88% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -₹6.37 Billion | -37.64% | 🇬🇧 UK |